Back to results
US 10,294,289 B2Granted
Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
AssigneesTherachon SAS, Inserm (Institut National De La Sante Et De La Recherche Medicale), Universite Nice Sophia Antipolis
InventorsElvire Gouze, Stéphanie Garcia
Life of this patent
Estimating the term…
Abstract
The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth retardation disorders, such as achondroplasia.
Claims21
A soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptide consisting of the amino acid sequence of SEQ ID NO:
- 33.
Dependencies are inferred from the claim text.